Latest from City of Hope

Loretta Erhunmwunsee, MD, thoracic surgeon, assistant professor of surgery, City of Hope, discusses disparities in the treatment of lung cancer.
Jae Y. Kim, MD, discusses developments with checkpoint inhibition in patients with resectable NSCLC.
Ravi Salgia, MD, PhD, discusses the evolution and current state of biomarker testing in the field of NSCLC.
Loretta Erhunmwunsee, MD, discusses the racial and socioeconomic disparities in lung cancer trials
City of Hope announced that it has appointed Michael A. Caligiuri, M.D., in a new executive leadership role as president of City of Hope National Medical Center and physician-in-chief.
Brentuximab vedotin (Adcetris) plus nivolumab (Opdivo) appeared active and well tolerated for the treatment of patients with relapsed/refractory Hodgkin lymphoma. 
Losing even some extra weight significantly reduces the risk of breast cancer for postmenopausal women, expert says. 
Jonathan N. Warner, MD, reconstructive urologist, City of Hope, discusses the future of surgery for patients with prostate cancer.
Publication Bottom Border
Border Publication